105 studies on GHRP-6 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
| Manufacturer | Batches | Avg purity | |
|---|---|---|---|
| Qingdao Sigma Chemical | 3 | 98.29% | View COA → |
| Aminos Research | 2 | 99.88% | View COA → |
| thelobster | 2 | 99.79% | View COA → |
| Optitropin EU | 2 | 99.75% | View COA → |
| Verified Peptides | 2 | 99.62% | View COA → |
| Peptide Crafters | 2 | 99.58% | View COA → |
Recent certificates: #10212 (99.611%) · #11992 (99.605%) · #15297 (99.815%) · #23436 (99.376%) · #19261 (99.476%) · #19329 (99.476%)
Manufacturers with published third-party certificates of analysis for GHRP-6. Open a vendor to see every batch we've verified.
This groundbreaking discovery represents a significant new challenge for global anti-doping agencies and laboratories, as these glycine-modified GHSs are unlikely to be detected by current, standard screening protocol…
This preclinical study provides compelling evidence that GHRP-6 holds significant promise as a therapeutic agent for combating severe muscle wasting conditions like cancer cachexia. Its demonstrated ability to stimula…
This study provides compelling evidence that GHRP-6 holds significant therapeutic potential for both the acute phase of lung injury and the chronic development of interstitial fibrosis. The ability of GHRP-6 to simult…
This research provides compelling evidence that GHRP-6 could be a promising therapeutic agent for preventing and treating the detrimental consequences of heart attacks. Its ability to mitigate adverse ventricular remo…
The widespread and increasing misuse of peptides poses a significant threat to the integrity of sports and the long-term health of athletes. This comprehensive review provides crucial insights for anti-doping organiza…
Free, no account — handy when you're working with GHRP-6.